What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors.
about
An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.An armamentarium of wart treatmentsAdjuvant properties of listeriolysin O protein in a DNA vaccination strategy.Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculatureAntiangiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoeditingListeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.T regulatory cells: aid or hindrance in the clearance of disease?Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.Immunotherapy for gynaecological malignancies.Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenesHPV vaccination: the beginning of the end of cervical cancer? - A Review.Perspectives for the development of human papillomavirus vaccines and immunotherapy.Inhibitory effect of live-attenuated Listeria monocytogenes-based vaccines expressing MIA gene on malignant melanoma.
P2860
Q33773435-22588141-5D16-41DE-A282-E1EDC2F205ACQ34001838-EB2EDE2C-4F1D-4B8A-85AE-8A12E968C0E1Q34267760-302AA23B-CE51-4712-BC7A-B0291DEBCAF1Q34415243-47A57CE8-8F25-4AA4-8BCA-DE64F3CED226Q34445188-A058C77C-9A41-440E-9EE7-6E10928C390EQ34797653-7900FB4F-79B2-4327-AFF4-27444CAA7B44Q35459820-0981FA07-D4DD-42A6-9386-87C71D63070CQ35768107-1EF5359F-0613-4773-8965-6EA96D97A2A3Q36239661-D4C2D205-90BC-4A31-AA1D-0177310A8796Q37196059-8E75179E-713F-4068-A7E8-1F94116D2DCFQ37410888-67B1A34B-68AD-4023-AC3D-FC00A45D9EB7Q37658876-FFBCCFEA-6482-4AC6-A488-6BEFAE94B535Q54296972-23057132-B64E-48AD-8419-E560519B8722
P2860
What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
What is needed for effective a ...... tor for HPV-associated tumors.
@ast
What is needed for effective a ...... tor for HPV-associated tumors.
@en
type
label
What is needed for effective a ...... tor for HPV-associated tumors.
@ast
What is needed for effective a ...... tor for HPV-associated tumors.
@en
prefLabel
What is needed for effective a ...... tor for HPV-associated tumors.
@ast
What is needed for effective a ...... tor for HPV-associated tumors.
@en
P1476
What is needed for effective a ...... ctor for HPV-associated tumors
@en
P2093
S Farzana Hussain
P2888
P304
P356
10.1007/S00262-004-0600-2
P577
2005-01-14T00:00:00Z